NCT00681525View on ClinicalTrials.gov

A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and Ezetimibe

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

June 30, 2008

Conditions
Pharmacokinetics
Interventions
DRUG

ABT-335

One ABT-335 135 mg capsule QD for 10 days

DRUG

Atorvastatin

One 80 mg tablet of atorvastatin QD for 10 days

DRUG

Ezetimibe

One ezetimibe 10 mg tablet QD for 10 days

Trial Locations (1)

32608

Site Reference ID/Investigator# 8087, Gainesville

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY

NCT00681525 - A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and Ezetimibe | Biotech Hunter | Biotech Hunter